Form 8-K - Current report:
SEC Accession No. 0001437749-23-007316
Filing Date
2023-03-21
Accepted
2023-03-21 09:00:50
Documents
14
Period of Report
2023-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20230320_8k.htm   iXBRL 8-K 24299
2 EXHIBIT 10.1 ex_490851.htm EX-10.1 26265
  Complete submission text file 0001437749-23-007316.txt   188145

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plse-20230317.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20230317_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20230317_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20230317_pre.xml EX-101.PRE 11689
8 EXTRACTED XBRL INSTANCE DOCUMENT plse20230320_8k_htm.xml XML 2557
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 23747947
SIC: 3841 Surgical & Medical Instruments & Apparatus